Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries
Eder-Czembirek C, Moser D, Holawe S, Brodowicz T, Ries J, Sulzbacher I, Selzer E (2019)
Publication Type: Journal article
Publication year: 2019
Journal
Book Volume: 74
DOI: 10.6061/clinics/2019/e701
Abstract
OBJECTIVES: Osteosarcoma of the jaw (OSAJ) is fundamentally different in clinical practice from its peripheral counterparts. Studies are difficult to conduct due to low incidence rates. The primary aim of this study was to provide for the first time a comprehensive retrospective analysis of the treatment concepts and outcome data of OSAJ patients treated at the University Hospital Vienna and to compare these with two recently published studies on OSAJ. The clinical study was accompanied by a biomarker study investigating the prognostic relevance of melanoma-associated antigen-A (MAGE-A) in OSAJ specimens.
Involved external institutions
Austria (AT)How to cite
APA:
Eder-Czembirek, C., Moser, D., Holawe, S., Brodowicz, T., Ries, J., Sulzbacher, I., & Selzer, E. (2019). Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries. Clinics, 74. https://dx.doi.org/10.6061/clinics/2019/e701
MLA:
Eder-Czembirek, Christina, et al. "Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries." Clinics 74 (2019).
BibTeX: Download